BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23063402)

  • 1. Glycan array analysis of the antigen repertoire targeted by tumor-binding antibodies.
    Gildersleeve JC; Wang B; Achilefu S; Tu Z; Xu M
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6839-43. PubMed ID: 23063402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Glycan Array Platform as a Tool to Identify Carbohydrate Antigens.
    Xia L; Gildersleeve JC
    Methods Mol Biol; 2015; 1331():27-40. PubMed ID: 26169733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of sialyl Lewis A and Lewis X modified protein cancer biomarkers using high density antibody arrays.
    Rho JH; Mead JR; Wright WS; Brenner DE; Stave JW; Gildersleeve JC; Lampe PD
    J Proteomics; 2014 Jan; 96():291-9. PubMed ID: 24185138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and structural basis for Lewis glycan recognition by a cancer-targeting antibody.
    Soliman C; Guy AJ; Chua JX; Vankemmelbeke M; McIntosh RS; Eastwood S; Truong VK; Elbourne A; Spendlove I; Durrant LG; Ramsland PA
    Biochem J; 2020 Sep; 477(17):3219-3235. PubMed ID: 32789497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidimensional glycan arrays for enhanced antibody profiling.
    Zhang Y; Campbell C; Li Q; Gildersleeve JC
    Mol Biosyst; 2010 Sep; 6(9):1583-91. PubMed ID: 20711537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sugar-binding proteins from fish: selection of high affinity "lambodies" that recognize biomedically relevant glycans.
    Hong X; Ma MZ; Gildersleeve JC; Chowdhury S; Barchi JJ; Mariuzza RA; Murphy MB; Mao L; Pancer Z
    ACS Chem Biol; 2013 Jan; 8(1):152-60. PubMed ID: 23030719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycan motif profiling reveals plasma sialyl-lewis x elevations in pancreatic cancers that are negative for sialyl-lewis A.
    Tang H; Singh S; Partyka K; Kletter D; Hsueh P; Yadav J; Ensink E; Bern M; Hostetter G; Hartman D; Huang Y; Brand RE; Haab BB
    Mol Cell Proteomics; 2015 May; 14(5):1323-33. PubMed ID: 25733690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous expression of type 1 and type 2 Lewis blood group antigens by Helicobacter pylori lipopolysaccharides. Molecular mimicry between h. pylori lipopolysaccharides and human gastric epithelial cell surface glycoforms.
    Monteiro MA; Chan KH; Rasko DA; Taylor DE; Zheng PY; Appelmelk BJ; Wirth HP; Yang M; Blaser MJ; Hynes SO; Moran AP; Perry MB
    J Biol Chem; 1998 May; 273(19):11533-43. PubMed ID: 9565568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunohistochemical examination of carcinomas in the pancreatoduodenal region and its non-malignant counterparts using monoclonal antibodies against Lewis blood group-related antigens and sialyl Tn antigen].
    Arima S
    Nihon Shokakibyo Gakkai Zasshi; 1991 May; 88(5):1221-30. PubMed ID: 1679138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological and immunohistochemical studies on sialylated carbohydrate antigens in colorectal carcinoma.
    Nakagoe T; Kusano H; Hirota M; Fukushima K; Hiratani K; Hara K; Tomita M
    Gastroenterol Jpn; 1991 Jun; 26(3):303-11. PubMed ID: 1716232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycan-specific antibodies as potential cancer biomarkers: a focus on microarray applications.
    Tikhonov A; Smoldovskaya O; Feyzkhanova G; Kushlinskii N; Rubina A
    Clin Chem Lab Med; 2020 Sep; 58(10):1611-1622. PubMed ID: 32324152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective Recognition of Carbohydrate Antigens by Germline Antibodies Isolated from AID Knockout Mice.
    DeLaitsch AT; Pridgen JR; Tytla A; Peach ML; Hu R; Farnsworth DW; McMillan AK; Flanagan N; Temme JS; Nicklaus MC; Gildersleeve JC
    J Am Chem Soc; 2022 Mar; 144(11):4925-4941. PubMed ID: 35282679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization of fucose-containing polysaccharides from Reishi mushroom induces antibodies to tumor-associated Globo H-series epitopes.
    Liao SF; Liang CH; Ho MY; Hsu TL; Tsai TI; Hsieh YS; Tsai CM; Li ST; Cheng YY; Tsao SM; Lin TY; Lin ZY; Yang WB; Ren CT; Lin KI; Khoo KH; Lin CH; Hsu HY; Wu CY; Wong CH
    Proc Natl Acad Sci U S A; 2013 Aug; 110(34):13809-14. PubMed ID: 23908400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation-induced expression of sialyl Lewis X-containing glycan structures on alpha 1-acid glycoprotein (orosomucoid) in human sera.
    De Graaf TW; Van der Stelt ME; Anbergen MG; van Dijk W
    J Exp Med; 1993 Mar; 177(3):657-66. PubMed ID: 7679706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of sialyl Lewis(a) (sLe (a), CA19-9) and construction of an immunogenic sLe(a) vaccine.
    Ragupathi G; Damani P; Srivastava G; Srivastava O; Sucheck SJ; Ichikawa Y; Livingston PO
    Cancer Immunol Immunother; 2009 Sep; 58(9):1397-405. PubMed ID: 19190907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling of serum antibodies with printed glycan array: room for data misinterpretation.
    Obukhova P; Piskarev V; Severov V; Pazynina G; Tuzikov A; Navakouski M; Shilova N; Bovin N
    Glycoconj J; 2011 Dec; 28(8-9):501-5. PubMed ID: 22057658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal Antibody Targeting Sialyl-di-Lewis
    Tivadar ST; McIntosh RS; Chua JX; Moss R; Parsons T; Zaitoun AM; Madhusudan S; Durrant LG; Vankemmelbeke M
    Mol Cancer Ther; 2020 Mar; 19(3):790-801. PubMed ID: 31871270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of IgG monoclonal antibodies to the tumor-associated antigen, CA-195.
    Kuus-Reichel K; Knott CL; McCormack RT; Guido MS; Beebe A
    Hybridoma; 1994 Feb; 13(1):31-6. PubMed ID: 8200656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Schistosoma mansoni shotgun O-glycan microarray and application to the discovery of new antigenic schistosome glycan motifs.
    van Diepen A; van der Plas AJ; Kozak RP; Royle L; Dunne DW; Hokke CH
    Int J Parasitol; 2015 Jun; 45(7):465-75. PubMed ID: 25819714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens.
    Fehres CM; Kalay H; Bruijns SC; Musaafir SA; Ambrosini M; van Bloois L; van Vliet SJ; Storm G; Garcia-Vallejo JJ; van Kooyk Y
    J Control Release; 2015 Apr; 203():67-76. PubMed ID: 25656175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.